CClinicalTrials.gg
CompletedNCT04051476Updated Apr 28, 2020

Dose-Response Relationship of Ginger Flour Footbaths in Healthy Volunteers

An interventional study of 3-g footbath and 6-g footbath in Thermogenesis by Different-dosage Ginger Flour Footbaths, sponsored by ARCIM Institute Academic Research in Complementary and Integrative Medicine. Completed at 1 site in Germany. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-04-28.

Sponsored by ARCIM Institute Academic Research in Complementary and Integrative Medicine · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

A study to explore whether different dosages of ginger flour in footbaths cause different effects on warmth development as well as on general well-being and the autonomic nervous system.

Read the detailed description

This is a four-arm randomized controlled trial with crossover design to explore the dose-response relationship of footbaths with different dosages of ginger flour in healthy volunteers, compared to a placebo control (footbath with warm water only). The main focus is on thermogenesis and warmth distribution, as assessed by high-resolution infrared thermography and questionnaire data before, during and after the intervention. In addition, effects on the autonomic nervous system are assessed by measuring various parameters of heart rate variability and pulse wave analysis.

02

Conditions studied

  • Thermogenesis by Different-dosage Ginger Flour Footbaths

Keywords

  • Ginger flour footbaths
  • Dose-response relationship
  • Thermogenesis
  • Infrared thermography
  • Heart rate variability
  • Healthy volunteers
03

In context

Lead sponsor

ARCIM Institute Academic Research in Complementary and Integrative Medicine is the lead sponsor of 30 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Written informed consent
  • Age between 18 and 55 years

Exclusion criteria

Exclusion Criteria:

  • Chronic skin lesions at the lower legs or feet
  • Known intolerance or hypersensitivity to ginger preparations
  • Cardiac arrhythmia
  • Cardiac pacemaker
  • Asthma bronchiale
  • Consumption of HRV-modulating medication (especially tricyclic antidepressants, beta blockers)
  • Pregnancy
  • Insufficient knowledge of the german language
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    3-g footbath

    Footbath with 3g ginger flour per liter of water

    Other: 3-g footbath

  • Experimental
    6-g footbath

    Footbath with 6g ginger flour per liter of water

    Other: 6-g footbath

  • Experimental
    12-g footbath

    Footbath with 12g ginger flour per liter of water

    Other: 12-g footbath

  • Placebo comparator
    Warm water footbath

    Footbath with warm water only

    Other: Warm water footbath

Interventions

  • Other3-g footbath

    A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 36 g ginger flour (3 g per l), followed by a ten-minute post-intervention rest period.

  • Other6-g footbath

    A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 72 g ginger flour (6 g per l), followed by a ten-minute post-intervention rest period.

  • Other12-g footbath

    A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 144 g ginger flour (12 g per l), followed by a ten-minute post-intervention rest period.

  • OtherWarm water footbath

    A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C), followed by a ten-minute post-intervention rest period.

06

What researchers measure

Primary outcomes

  1. 2-item warmth perception measure at the feet after the footbath

    Self-reported warmth perception at both feet, assessed with the "Herdecke warmth perception questionnaire" immediately after the footbath (t2). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4.

    Time frame: Immediately after the footbath, timepoint 2 (t2)

Secondary outcomes

  1. 2-item warmth perception measure at the feet at t1 and t3

    Self-reported warmth perception at both feet, assessed with the "Herdecke warmth perception questionnaire" immediately before (t1) and 10 minutes following the footbath (t3). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4.

    Time frame: Immediately before (t1) and 10 minutes following the footbath (t3)

  2. 2-item warmth perception measure at the hands at t1, t2 and t3

    Self-reported warmth perception at both hands, assessed with the "Herdecke warmth perception questionnaire" immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4.

    Time frame: Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3).

  3. 2-item warmth perception measure at the head at t1, t2 and t3

    Self-reported warmth perception at the head, assessed with the "Herdecke warmth perception questionnaire" immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4.

    Time frame: Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  4. 1-item overall warmth perception measure at t1, t2 and t3

    Self-reported overall warmth perception, assessed with the "Herdecke warmth perception questionnaire" immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3). The item is scored 0-4 (0 = cold; 4 = hot).

    Time frame: Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  5. Warmth perception and skin stimulus at the feet during the footbath

    Self-reported perception of warmth and skin stimulus during the footbath, assessed with a dynamic warmth and skin stimulus visual analog scale (VAS), applied once per minute (0 = cold/no stimulus; 10 = very hot/very strong stimulus).

    Time frame: Up to 20 minutes

  6. Well-being at t1, t2 and t3

    Self-reported well-being, assessed with the "Basler Befindlichkeits-Skala" (Basel Mood Questionnaire, BBS) immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3). (BBS: 16 items; 7-point rating scale; higher values represent a better outcome.)

    Time frame: Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  7. Skin surface temperature at the feet at t1, t2 and t3

    Skin surface temperature (°C) at both feet, measured with high-resolution infrared thermography immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3).

    Time frame: Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  8. Skin surface temperature at the lower legs at t1, t2 and t3

    Skin surface temperature (°C) at both lower legs, measured with high-resolution infrared thermography immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3).

    Time frame: Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  9. Skin surface temperature at the hands at t1, t2 and t3

    Skin surface temperature (°C) at both hands, measured with high-resolution infrared thermography immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3).

    Time frame: Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  10. Skin surface temperature in the face at t1, t2 and t3

    Skin surface temperature (°C) in the face, measured with high-resolution infrared thermography immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3).

    Time frame: Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  11. HRV analysis: HF

    High frequency power band (0.15-0.40 Hz) (ms2) from frequency domain analysis, obtained from ECG recordings throughout the intervention and the pre- and post-intervention rest periods (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  12. HRV analysis: LF

    Low frequency power band (0.04-0.15 Hz) (ms2) from frequency domain analysis (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  13. HRV analysis: LF/HF ratio

    LF/HF ratio = ratio of two bands from frequency domain analysis: LF band (0.04-0.15 Hz), HF band (0.15-0.40 Hz) (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  14. HRV analysis: SDNN

    Standard deviation of normal to normal (NN) intervals (ms) (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  15. HRV analysis: RMSSD

    Root mean square of successive differences (ms) (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  16. HRV analysis: pNN50

    Percentage of successive NN intervals that differ from each other by more than 50 ms (%) (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  17. Pulse wave analysis: Pulse Transit Time

    Pulse Transit Time (PTT, ms), obtained from pulse oximetry recordings throughout the intervention and the pre- and post-intervention rest periods (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  18. Pulse wave analysis: Reflection Index

    Reflection Index (RI, %), obtained from pulse oximetry recordings throughout the intervention and the pre- and post-intervention rest periods (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  19. Pulse wave analysis: Perfusion Index

    Perfusion Index (PI, %), obtained from pulse oximetry recordings throughout the intervention and the pre- and post-intervention rest periods (VitaGuard® 3100 monitor, getemed, Germany).

    Time frame: Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)

  20. Evening morning protocol: perception of warmth and stimulus at the feet

    Self-reported lasting effects of the footbaths at the feet, indicated on a seven-point rating scale (higher values represent a better outcome)

    Time frame: On the evening of the footbath, before going to sleep; on the following morning, within 15 minutes after waking up

  21. Evening morning protocol: skin condition

    Self-reported lasting effects of the footbaths on skin condition, indicated on a seven-point rating scale (higher values represent a better outcome)

    Time frame: On the evening of the footbath, before going to sleep; on the following morning, within 15 minutes after waking up

  22. Evening morning protocol: general well-being

    Self-reported lasting effects of the footbaths on general well-being, indicated on a seven-point rating scale (higher values represent a better outcome)

    Time frame: On the evening of the footbath, before going to sleep; on the following morning, within 15 minutes after waking up

  23. Morning protocol: sleep quality

    Self-reported sleep quality during the night following the footbaths, indicated on a seven-point rating scale (higher values represent a better outcome)

    Time frame: In the morning after the footbath, within 15 minutes after waking up

07

Study locations

1 site
  • Arcim Institute
    Filderstadt, Baden-Württemberg 70794, Germany
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.

Supporting information: Study protocol, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04051476
Lead sponsor
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Collaborators
University Hospital Tuebingen
Responsible party
Sponsor
First posted
Aug 9, 2019
Start date
Sep 16, 2019
Primary completion
Jan 30, 2020
Completion
Jan 31, 2020
Last update
Apr 28, 2020

Study contacts

Jan Vagedes, Dr.
principal investigator · Arcim Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion